Epinine (BioDeep_00000003451)
Secondary id: BioDeep_00001868739
human metabolite Endogenous
代谢物信息卡片
4-[2-(Methylamino)ethyl]-1,2-benzenediol, 9ci
化学式: C9H13NO2 (167.0946)
中文名称: N-2-(3,4-二羟基苯基)乙基甲胺
谱图信息:
最多检出来源 Viridiplantae(plant) 6.53%
分子结构信息
SMILES: c1c(c(cc(c1)CCNC)O)O
InChI: InChI=1S/C9H13NO2/c1-10-5-4-7-2-3-8(11)9(12)6-7/h2-3,6,10-12H,4-5H2,1H3
描述信息
Epinine, also known as deoxyepinephrine or deoxyadrenaline, is a member of the class of compounds known as catecholamines and derivatives. These compounds contain 4-(2-aminoethyl)pyrocatechol [4-(2-aminoethyl)benzene-1,2-diol] or a derivative thereof formed by substitution. Epinine exists as a solid, and is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). Epinine is an alkaloid from Vicia faba and can be found in pulses. Epinine is a dopamine and epinephrine derivative.
KEIO_ID E013
同义名列表
24 个代谢物同义名
4-[2-(Methylamino)ethyl]-1,2-benzenediol, 9ci; 1-(3,4-Dihydroxyphenyl)-2-methylaminoethane; N-Methyl-2-(3,4-dihydroxyphenyl)ethylamine; 4-[2-(Methylamino)ethyl]pyrocatechol, 8ci; 4-(2-(Methylamino)ethyl)-1,2-benzenediol; 4-(2-Methylamino-ethyl)-benzene-1,2-diol; 4-[2-(Methylamino)ethyl]-1,2-benzenediol; 4-[2-(methylamino)ethyl]benzene-1,2-diol; N-Methyl-3,4-dihydroxyphenethylamine; 3,4-Dihydroxy-N-methylphenethylamine; 4-(2-Methylaminoethyl)pyrocatechol; 4-(beta-Methylaminoethyl)catechol; n-methyldopamine hydrochloride; 4-(b-Methylaminoethyl)catechol; 4-(Β-methylaminoethyl)catechol; N-Methyldopamine; Deoxyepinephrine; Deoxyadrenaline; Methyldopamine; Epyamine; epinine; Epinin; Epinine; Epinine
数据库引用编号
22 个数据库交叉引用编号
- ChEBI: CHEBI:10554
- KEGG: C07453
- PubChem: 4382
- HMDB: HMDB0032020
- Metlin: METLIN66649
- DrugBank: DB13917
- ChEMBL: CHEMBL31088
- Wikipedia: Deoxyepinephrine
- MeSH: Deoxyepinephrine
- KNApSAcK: C00042777
- foodb: FDB008718
- chemspider: 4229
- CAS: 501-15-5
- MoNA: KO002840
- MoNA: KO002843
- MoNA: KO002841
- MoNA: KO002842
- MoNA: KO002839
- PMhub: MS000009697
- PubChem: 9656
- NIKKAJI: J6.117D
- KNApSAcK: 10554
分类词条
相关代谢途径
Reactome(0)
BioCyc(0)
PlantCyc(0)
代谢反应
0 个相关的代谢反应过程信息。
Reactome(0)
BioCyc(0)
WikiPathways(0)
Plant Reactome(0)
INOH(0)
PlantCyc(0)
COVID-19 Disease Map(0)
PathBank(0)
PharmGKB(0)
3 个相关的物种来源信息
- 9606 - Homo sapiens: -
- 138013 - Senegalia berlandieri: 10.1016/S0031-9422(97)00240-9
- 205076 - Vachellia rigidula: 10.1016/S0031-9422(97)01022-4
在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：
- PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
- NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
- Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
- Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。
点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。
文献列表
- Mark J Henderson, Kathleen A Trychta, Shyh-Ming Yang, Susanne Bäck, Adam Yasgar, Emily S Wires, Carina Danchik, Xiaokang Yan, Hideaki Yano, Lei Shi, Kuo-Jen Wu, Amy Q Wang, Dingyin Tao, Gergely Zahoránszky-Kőhalmi, Xin Hu, Xin Xu, David Maloney, Alexey V Zakharov, Ganesha Rai, Fumihiko Urano, Mikko Airavaara, Oksana Gavrilova, Ajit Jadhav, Yun Wang, Anton Simeonov, Brandon K Harvey. A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
Cell reports.
2021 04; 35(4):109040. doi:
10.1016/j.celrep.2021.109040. [PMID: 33910017] - Yao Yao, Cheng-Shuai Jiang, Na Sun, Wei-Qi Li, Yang Niu, Huai-Qin Han, Zhen-Hua Miao, Xun-Xia Zhao, Jing Zhao, Juan Li. Tamaractam, a New Bioactive Lactam from Tamarix ramosissima, Induces Apoptosis in Rheumatoid Arthritis Fibroblast-Like Synoviocytes.
Molecules (Basel, Switzerland).
2017 Jan; 22(1):. doi:
10.3390/molecules22010096. [PMID: 28075411] - Juan M Decara, Francisco Javier Pavón, Juan Suárez, Miguel Romero-Cuevas, Elena Baixeras, Mariam Vázquez, Patricia Rivera, Ana L Gavito, Bruno Almeida, Jesús Joglar, Rafael de la Torre, Fernando Rodríguez de Fonseca, Antonia Serrano. Treatment with a novel oleic-acid-dihydroxyamphetamine conjugation ameliorates non-alcoholic fatty liver disease in obese Zucker rats.
Disease models & mechanisms.
2015 Oct; 8(10):1213-25. doi:
10.1242/dmm.019919. [PMID: 26438694] - Andrea E Schwaninger, Markus R Meyer, Marilyn A Huestis, Hans H Maurer. Development and validation of LC-HRMS and GC-NICI-MS methods for stereoselective determination of MDMA and its phase I and II metabolites in human urine.
Journal of mass spectrometry : JMS.
2011 Jul; 46(7):603-14. doi:
10.1002/jms.1929. [PMID: 21656610] - E Escubedo, S Abad, I Torres, J Camarasa, D Pubill. Comparative neurochemical profile of 3,4-methylenedioxymethamphetamine and its metabolite alpha-methyldopamine on key targets of MDMA neurotoxicity.
Neurochemistry international.
2011 Jan; 58(1):92-101. doi:
10.1016/j.neuint.2010.11.001. [PMID: 21074589] - Melanie Mueller, Jie Yuan, Anne Felim, Anne Neudörffer, Frank T Peters, Hans H Maurer, Una D McCann, Martine Largeron, George A Ricaurte. Further studies on the role of metabolites in (+/-)-3,4-methylenedioxymethamphetamine-induced serotonergic neurotoxicity.
Drug metabolism and disposition: the biological fate of chemicals.
2009 Oct; 37(10):2079-86. doi:
10.1124/dmd.109.028340. [PMID: 19628751] - Melanie Mueller, Erin A Kolbrich-Spargo, Frank T Peters, Marilyn A Huestis, George A Ricaurte, Hans H Maurer. Hydrolysis of 3,4-methylenedioxymethamphetamine (MDMA) metabolite conjugates in human, squirrel monkey, and rat plasma.
Analytical and bioanalytical chemistry.
2009 Mar; 393(6-7):1607-17. doi:
10.1007/s00216-009-2607-1. [PMID: 19183967] - Melanie Mueller, Frank T Peters, Marilyn A Huestis, George A Ricaurte, Hans H Maurer. Simultaneous liquid chromatographic-electrospray ionization mass spectrometric quantification of 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) and its metabolites 3,4-dihydroxymethamphetamine, 4-hydroxy-3-methoxymethamphetamine and 3,4-methylenedioxyamphetamine in squirrel monkey and human plasma after acidic conjugate cleavage.
Forensic science international.
2009 Jan; 184(1-3):64-8. doi:
10.1016/j.forsciint.2008.12.002. [PMID: 19131196] - Melanie Mueller, Frank T Peters, Hans H Maurer, Una D McCann, George A Ricaurte. Nonlinear pharmacokinetics of (+/-)3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy') and its major metabolites in squirrel monkeys at plasma concentrations of MDMA that develop after typical psychoactive doses.
The Journal of pharmacology and experimental therapeutics.
2008 Oct; 327(1):38-44. doi:
10.1124/jpet.108.141366. [PMID: 18591215] - Mary C Perianayagam, Pura J Requintina, Bertrand L Jaber, Gregory F Oxenkrug. Effect of methyl derivatives of dopamine on tumor necrosis factor alpha and lipid peroxidation.
Annals of the New York Academy of Sciences.
2007 Dec; 1122(?):253-9. doi:
10.1196/annals.1403.018. [PMID: 18077578] - Albrecht Pfäfflin, Erwin Schleicher, Karsten Müssig. 3-O-methyldopamine (3-O-methoxytyramine) interferes with the internal standard 3,4-dihydroxybenzylamine in a plasma catecholamine HPLC method.
Clinical chemistry.
2007 Nov; 53(11):1976-7. doi:
10.1373/clinchem.2007.094276. [PMID: 17954499] - Matthew L Banks, Jon E Sprague, David F Kisor, Paul W Czoty, David E Nichols, Michael A Nader. Ambient temperature effects on 3,4-methylenedioxymethamphetamine-induced thermodysregulation and pharmacokinetics in male monkeys.
Drug metabolism and disposition: the biological fate of chemicals.
2007 Oct; 35(10):1840-5. doi:
10.1124/dmd.107.016261. [PMID: 17640955] - Melanie Mueller, Frank T Peters, George A Ricaurte, Hans H Maurer. Validated liquid chromatographic-electrospray ionization mass spectrometric assay for simultaneous determination of 3,4-methylenedioxymethamphetamine and its metabolites 3,4-methylenedioxyamphetamine, 3,4-dihydroxymethamphetamine, and 4-hydroxy-3-methoxymethamphetamine in squirrel monkey plasma.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
2007 Aug; 855(2):262-70. doi:
10.1016/j.jchromb.2007.06.034. [PMID: 17646137] - Chunyu Zeng, Robin A Felder, Pedro A Jose. A new approach for treatment of hypertension: modifying D1 dopamine receptor function.
Cardiovascular & hematological agents in medicinal chemistry.
2006 Oct; 4(4):369-77. doi:
10.2174/187152506778520727. [PMID: 17073613] - Isabel Escobedo, Esther O'Shea, Laura Orio, Veronica Sanchez, Mireia Segura, Rafael de la Torre, Magi Farre, Alfred Richard Green, Maria Isabel Colado. A comparative study on the acute and long-term effects of MDMA and 3,4-dihydroxymethamphetamine (HHMA) on brain monoamine levels after i.p. or striatal administration in mice.
British journal of pharmacology.
2005 Jan; 144(2):231-41. doi:
10.1038/sj.bjp.0706071. [PMID: 15665862] - Nieves Pizarro, Magí Farré, Mitona Pujadas, Ana Ma Peiró, Pere N Roset, Jesús Joglar, Rafael de la Torre. Stereochemical analysis of 3,4-methylenedioxymethamphetamine and its main metabolites in human samples including the catechol-type metabolite (3,4-dihydroxymethamphetamine).
Drug metabolism and disposition: the biological fate of chemicals.
2004 Sep; 32(9):1001-7. doi:
NULL. [PMID: 15319342] - Márcia Carvalho, Nuno Milhazes, Fernando Remião, Fernanda Borges, Eduarda Fernandes, Francisco Amado, Terrence J Monks, Félix Carvalho, Maria Lourdes Bastos. Hepatotoxicity of 3,4-methylenedioxyamphetamine and alpha-methyldopamine in isolated rat hepatocytes: formation of glutathione conjugates.
Archives of toxicology.
2004 Jan; 78(1):16-24. doi:
10.1007/s00204-003-0510-7. [PMID: 14586543] - Mi Kyung Pyo, Hye Sook Yun-Choi, Young-Jin Hong. Apparent heterogeneous responsiveness of human platelet rich plasma to catecholamines.
Platelets.
2003 May; 14(3):171-8. doi:
10.1080/0953710031000092785. [PMID: 12850841] - M Segura, J Ortuño, J A McLure, M Pujadas, N Pizarro, M Farré, A Llebaria, J Joglar, J Segura, R de la Torre. High-performance liquid chromatography with electrochemical detection applied to the analysis of 3,4-dihydroxymethamphetamine in human plasma and urine.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
2002 Apr; 769(2):313-21. doi:
10.1016/s1570-0232(02)00020-x. [PMID: 11996497] - Nieves Pizarro, Jordi Ortuño, Magí Farré, Cándido Hernández-López, Mitona Pujadas, Amadeu Llebaria, Jesús Joglar, Pere N Roset, Marta Mas, Jordi Segura, Jordi Camí, Rafael de la Torre. Determination of MDMA and its metabolites in blood and urine by gas chromatography-mass spectrometry and analysis of enantiomers by capillary electrophoresis.
Journal of analytical toxicology.
2002 Apr; 26(3):157-65. doi:
10.1093/jat/26.3.157. [PMID: 11991532] - M Segura, J Ortuño, M Farré, J A McLure, M Pujadas, N Pizarro, A Llebaria, J Joglar, P N Roset, J Segura, R de La Torre. 3,4-Dihydroxymethamphetamine (HHMA). A major in vivo 3,4-methylenedioxymethamphetamine (MDMA) metabolite in humans.
Chemical research in toxicology.
2001 Sep; 14(9):1203-8. doi:
10.1021/tx010051p. [PMID: 11559034] - H L Hillege, A R Girbes, P J de Kam, F Boomsma, D de Zeeuw, A Charlesworth, J R Hampton, D J van Veldhuisen. Renal function, neurohormonal activation, and survival in patients with chronic heart failure.
Circulation.
2000 Jul; 102(2):203-10. doi:
10.1161/01.cir.102.2.203. [PMID: 10889132] - R de la Torre, M Farré, J Ortuño, M Mas, R Brenneisen, P N Roset, J Segura, J Camí. Non-linear pharmacokinetics of MDMA ('ecstasy') in humans.
British journal of clinical pharmacology.
2000 Feb; 49(2):104-9. doi:
10.1046/j.1365-2125.2000.00121.x. [PMID: 10671903] - J Feenstra, B A in't Veld, P D van der Linden, D E Grobbee, B H Stricker. Risk factors for mortality in users of ibopamine.
British journal of clinical pharmacology.
1998 Jul; 46(1):71-7. doi:
10.1046/j.1365-2125.1998.00046.x. [PMID: 9690952] - K M Yee, A D Struthers. Can drug effects on mortality in heart failure be predicted by any surrogate measure?.
European heart journal.
1997 Dec; 18(12):1860-4. doi:
10.1093/oxfordjournals.eurheartj.a015193. [PMID: 9447312] - H He, C M Stein, B Christman, A J Wood. Determination of catecholamines in sheep plasma by high-performance liquid chromatography with electrochemical detection: comparison of deoxyepinephrine and 3,4-dihydroxybenzylamine as internal standard.
Journal of chromatography. B, Biomedical sciences and applications.
1997 Nov; 701(1):115-9. doi:
10.1016/s0378-4347(97)00343-5. [PMID: 9389345] - B H Stricker, J Feenstra, J P Ottervanger, A J Porsius, D E Grobbee. A nested case-control study on mortality in users of ibopamine.
The Netherlands journal of medicine.
1997 Nov; 51(5):163-8. doi:
10.1016/s0300-2977(97)00053-3. [PMID: 9455095] - A C Teisman, D J van Veldhuisen, E Scholtens, W Maselbas, W H van Gilst. Effects of selective dopaminergic receptor stimulation on ventricular remodeling after experimental myocardial infarction in rats.
Journal of cardiac failure.
1997 Sep; 3(3):199-205. doi:
10.1016/s1071-9164(97)90016-6. [PMID: 9330128] - H Buikema, D J van Veldhuisen, H Hegeman, W H van Gilst. Early pharmacologic intervention may prevent the deterioration in endothelial function after experimental myocardial infarction in rats: effects of ibopamine and captopril.
Journal of cardiac failure.
1997 Jun; 3(2):125-32. doi:
10.1016/s1071-9164(97)90046-4. [PMID: 9220312] - R Andrews, A Charlesworth, A Evans, A J Cowley. A double-blind, cross-over comparison of the effects of a loop diuretic and a dopamine receptor agonist as first line therapy in patients with mild congestive heart failure.
European heart journal.
1997 May; 18(5):852-7. doi:
10.1093/oxfordjournals.eurheartj.a015351. [PMID: 9152656] - H J Helmlin, K Bracher, D Bourquin, D Vonlanthen, R Brenneisen. Analysis of 3,4-methylenedioxymethamphetamine (MDMA) and its metabolites in plasma and urine by HPLC-DAD and GC-MS.
Journal of analytical toxicology.
1996 Oct; 20(6):432-40. doi:
10.1093/jat/20.6.432. [PMID: 8889680] - B M Szabó, D J van Veldhuisen, P H van der Burgh, J Kruik, A R Girbes, K I Lie. Clinical and autonomic effects of ibopamine as adjunct to angiotensin-converting enzyme inhibitors in chronic heart failure.
Journal of cardiac failure.
1996 Sep; 2(3):185-92. doi:
10.1016/s1071-9164(96)80040-6. [PMID: 8891856] - H K Ensslin, K A Kovar, H H Maurer. Toxicological detection of the designer drug 3,4-methylenedioxyethylamphetamine (MDE, 'Eve') and its metabolites in urine by gas chromatography-mass spectrometry and fluorescence polarization immunoassay.
Journal of chromatography. B, Biomedical applications.
1996 Aug; 683(2):189-97. doi:
10.1016/0378-4347(96)00129-6. [PMID: 8891915] - R H Schwinger, C Schulz, K Brixius, M Böhm, J Müller-Ehmsen, E Erdmann. Effect of epinine on tension of human renal arteries.
Naunyn-Schmiedeberg's archives of pharmacology.
1996 Aug; 354(3):343-7. doi:
10.1007/bf00171066. [PMID: 8878065] - S Stefoni, G Mosconi, G La Manna, V Bonomini, V Mioli, E Fanciulli, C Feletti, D Docci, P Cappelli, M Bonomini, F Locatelli, P Marai, G Bazzato, A Fracasso, D Brancaccio, C Galmozzi, L Scarpioni, E Sverzellati, G B Sorba, M Cossu, G Piccoli, D Roccatello, L Oldrizzi, V De Biase, A A Bignamini. Low-dosage ibopamine treatment in progressive renal failure: a long-term multicentre trial.
American journal of nephrology.
1996; 16(6):489-99. doi:
10.1159/000169049. [PMID: 8955760] - L Dei Cas, M Metra, S Nodari, D Raccagni. [Clinical efficacy of oral dopaminergic agents: new findings].
Cardiologia (Rome, Italy).
1995 Dec; 40(12 Suppl 1):131-8. doi:
NULL. [PMID: 8998705] - A Daul, M Elter-Schulz, U Poller, F Jockenhövel, K Pönicke, F Boomsma, A J Man in't Veld, R F Schäfes, O E Brodde. Dose-dependent separation of dopaminergic and adrenergic effects of epinine in healthy volunteers.
Naunyn-Schmiedeberg's archives of pharmacology.
1995 Oct; 352(4):429-37. doi:
10.1007/bf00172781. [PMID: 8532072] - J Brouwer, D J van Veldhuisen, A J Man in 't Veld, P H Dunselman, F Boomsma, J Haaksma, K I Lie. Heart rate variability in patients with mild to moderate heart failure: effects of neurohormonal modulation by digoxin and ibopamine. The Dutch Ibopamine Multicenter Trial (DIMT) Study Group.
Journal of the American College of Cardiology.
1995 Oct; 26(4):983-90. doi:
10.1016/0735-1097(95)00285-3. [PMID: 7560628] - D J van Veldhuisen, O E Brodde, W H van Gilst, C Schulze, H Hegeman, R L Anthonio, E Scholtens, P A de Graeff, H Wesseling, K I Lie. Relation between myocardial beta-adrenoceptor density and hemodynamic and neurohumoral changes in a rat model of chronic myocardial infarction: effects of ibopamine and captopril.
Cardiovascular research.
1995 Sep; 30(3):386-93. doi:
10.1016/s0008-6363(95)00058-5. [PMID: 7585830] - A G Lieverse, A R Girbes, D J Van Veldhuisen, A J Smit, J G Zijlstra, S Meijer, K I Lie, W D Reitsma. The effects of ibopamine on glomerular filtration rate and plasma norepinephrine remain preserved during prolonged treatment in patients with congestive heart failure.
European heart journal.
1995 Jul; 16(7):937-42. doi:
10.1093/oxfordjournals.eurheartj.a061028. [PMID: 7498209] - M Metra, C Missale, P F Spano, L D Cas. Dopaminergic drugs in congestive heart failure: hemodynamic and neuroendocrine responses to ibopamine, dopamine, and dihydroergotoxine.
Journal of cardiovascular pharmacology.
1995 May; 25(5):732-40. doi:
10.1097/00005344-199505000-00008. [PMID: 7630152] - D J van Veldhuisen, J Brouwer, A J Man in 't Veld, P H Dunselman, F Boomsma, K I Lie. Progression of mild untreated heart failure during six months follow-up and clinical and neurohumoral effects of ibopamine and digoxin as monotherapy. DIMT Study Group. Dutch Ibopamine Multicenter Trial.
The American journal of cardiology.
1995 Apr; 75(12):796-800. doi:
10.1016/s0002-9149(99)80414-7. [PMID: 7717282] - H Pouleur. Neurohormonal and hemodynamic effects of ibopamine.
Clinical cardiology.
1995 Mar; 18(3 Suppl I):I17-21. doi:
10.1002/clc.4960181306. [PMID: 7743694] - A G Lieverse, D J van Veldhuisen, A J Smit, J G Zijlstra, S Meijer, W D Reitsma, K I Lie, A R Girbes. Renal and systemic hemodynamic effects of ibopamine in patients with mild to moderate congestive heart failure.
Journal of cardiovascular pharmacology.
1995 Mar; 25(3):361-7. doi:
10.1097/00005344-199503000-00003. [PMID: 7769799] - M Metra, L Dei Cas. Clinical efficacy of ibopamine in patients with chronic heart failure.
Clinical cardiology.
1995 Mar; 18(3 Suppl I):I22-31. doi:
10.1002/clc.4960181307. [PMID: 7743695] - A R Girbes, A R Milner, B V McCloskey, J H Zwaveling, D J van Veldhuisen, J G Zijlstra, K I Lie. Oral ibopamine substitution in patients with intravenous dopamine dependence.
Cardiology.
1995; 86(5):391-5. doi:
10.1159/000176908. [PMID: 7585741] - W H van Gilst, D J van Veldhuisen, H Hegeman, H Buikema, E Scholtens, P A de Graeff, K I Lie. Effect of ibopamine on ventricular remodeling after experimental myocardial infarction: a comparison with captopril.
Journal of cardiovascular pharmacology.
1994 Jul; 24(1):171-4. doi:
10.1097/00005344-199407000-00026. [PMID: 7521484] - D J van Veldhuisen, W H van Gilst, B J de Smet, P A de Graeff, E Scholtens, H Buikema, A R Girbes, H Wesseling, K I Lie. Neurohumoral and hemodynamic effects of ibopamine in a rat model of chronic myocardial infarction and heart failure.
Cardiovascular drugs and therapy.
1994 Apr; 8(2):245-50. doi:
10.1007/bf00877333. [PMID: 7918137] - M F Rousseau, M A Konstam, C R Benedict, J Donckier, L Galanti, J Melin, D Kinan, S Ahn, J M Ketelslegers, H Pouleur. Progression of left ventricular dysfunction secondary to coronary artery disease, sustained neurohormonal activation and effects of ibopamine therapy during long-term therapy with angiotensin-converting enzyme inhibitor.
The American journal of cardiology.
1994 Mar; 73(7):488-93. doi:
10.1016/0002-9149(94)90680-7. [PMID: 7908164] - H Buikema, W H van Gilst, D J van Veldhuisen, B J de Smet, E Scholtens, K I Lie, H Wesseling. Endothelium dependent relaxation in two different models of chronic heart failure and the effect of ibopamine.
Cardiovascular research.
1993 Dec; 27(12):2118-24. doi:
10.1093/cvr/27.12.2118. [PMID: 8313417] - D J van Veldhuisen, A J Man in 't Veld, P H Dunselman, D J Lok, H J Dohmen, J C Poortermans, A J Withagen, W H Pasteuning, J Brouwer, K I Lie. Double-blind placebo-controlled study of ibopamine and digoxin in patients with mild to moderate heart failure: results of the Dutch Ibopamine Multicenter Trial (DIMT).
Journal of the American College of Cardiology.
1993 Nov; 22(6):1564-73. doi:
10.1016/0735-1097(93)90579-p. [PMID: 7901256] - F Boomsma, L J van Woerkens, A J Man in 't Veld, P D Verdouw, M A Schalekamp. High activity of semicarbazide-sensitive amine oxidase (SSAO): an important source of errors in the determination of the concentration of dopamine in pig plasma.
Journal of cardiovascular pharmacology.
1993 Aug; 22(2):198-202. doi:
10.1097/00005344-199308000-00004. [PMID: 7692157] - P L Rensma, A H van den Meiracker, F Boomsma, A J Man in 't Veld, M A Schalekamp. Effects of ibopamine on postural hypotension in pure autonomic failure.
Journal of cardiovascular pharmacology.
1993 Jun; 21(6):863-8. doi:
10.1097/00005344-199306000-00003. [PMID: 7687709] - L De Caro, A Ghizzi, M T Zunino. Kinetics and pharmacodynamic effects of a novel prodrug of N-methyldopamine at single dose in healthy volunteers.
Arzneimittel-Forschung.
1993 Jun; 43(6):651-5. doi:
NULL. [PMID: 8352818] - D J van Veldhuisen, A R Girbes, S A van den Broek, P A de Graeff, W H van Gilst, K I Lie. Effects of ibopamine on the increase in plasma norepinephrine levels during exercise in congestive heart failure.
The American journal of cardiology.
1993 Apr; 71(11):992-4. doi:
10.1016/0002-9149(93)90920-8. [PMID: 8465795] - R H Schwinger, M Böhm, C Schulz, U Schmidt, U Schmidt, B Schmid, H Dienemann, B Reichart, E Erdmann. Cardiac inotropic as well as coronary and pulmonary artery actions of epinine in human isolated tissues.
The Journal of pharmacology and experimental therapeutics.
1993 Apr; 265(1):346-57. doi:
. [PMID: 8386240] - A R Girbes, C J Kalisvaart, D J Van Veldhuisen, E T Tan, A J Smit, W D Reitsma, W H Pasteuning. Effects of ibopamine on renal haemodynamics in patients with severe congestive heart failure.
European heart journal.
1993 Feb; 14(2):279-83. doi:
10.1093/eurheartj/14.2.279. [PMID: 8095455] - O E Brodde, I Klusmann, M Wojcik, A J Man in't Veld, F Boomsma, M C Michel. Lack of desensitization of alpha- and beta-adrenoceptor function during chronic treatment of healthy volunteers with ibopamine, an orally active dopamine receptor agonist.
European journal of clinical pharmacology.
1993; 44(3):283-6. doi:
10.1007/bf00271373. [PMID: 8098281] - L J van Woerkens, F Boomsma, A J Man in 't Veld, M M Bevers, P D Verdouw. Differential cardiovascular and neuroendocrine effects of epinine and dopamine in conscious pigs before and after adrenoceptor blockade.
British journal of pharmacology.
1992 Oct; 107(2):303-10. doi:
10.1111/j.1476-5381.1992.tb12742.x. [PMID: 1330172] - L Dei Cas, M Metra, O Visioli. Effects of acute and chronic ibopamine administration on resting and exercise hemodynamics, plasma catecholamines and functional capacity of patients with chronic congestive heart failure.
The American journal of cardiology.
1992 Sep; 70(6):629-34. doi:
10.1016/0002-9149(92)90203-b. [PMID: 1354938] - A R Girbes, D J Van Veldhuisen, A J Smit. [New dopamine agonists in cardiovascular therapy].
Presse medicale (Paris, France : 1983).
1992 Aug; 21(27):1287-91. doi:
NULL. [PMID: 1359528] - A R Girbes, D J Van Veldhuisen, R G Grevink, A J Smith, W D Reitsma. Effects of ibopamine on exercise-induced increase in norepinephrine in normal men.
Journal of cardiovascular pharmacology.
1992 Mar; 19(3):371-4. doi:
10.1097/00005344-199203000-00011. [PMID: 1378116] - F Boomsma, G Alberts, F A van der Hoorn, A J Man in 't Veld, M A Schalekamp. Simultaneous determination of free catecholamines and epinine and estimation of total epinine and dopamine in plasma and urine by high-performance liquid chromatography with fluorimetric detection.
Journal of chromatography.
1992 Feb; 574(1):109-17. doi:
10.1016/0378-4347(92)80104-x. [PMID: 1629273] - M F Rousseau, J Raigoso, C van Eyll, H Van Mechelen, N R Musso, G Lotti, H Pouleur. Effects of intravenous epinine administration on left ventricular systolic performance, coronary hemodynamics, and circulating catecholamines in patients with heart failure.
Journal of cardiovascular pharmacology.
1992 Feb; 19(2):155-62. doi:
10.1097/00005344-199202000-00001. [PMID: 1376782] - R A Lefebvre, G De Wilde, M T Rosseel, D Duprez, J De Sutter, F Pocchiari. Investigation of a possible pharmacokinetic interaction between ibopamine and isosorbide-5-mononitrate.
European journal of clinical pharmacology.
1992; 42(5):549-52. doi:
10.1007/bf00314867. [PMID: 1607003] - D J Van Veldhuisen, H J Crijns, A R Girbes, T J Tobé, A C Wiesfeld, K I Lie. Electrophysiologic profile of ibopamine in patients with congestive heart failure and ventricular tachycardia and relation to its effects on hemodynamics and plasma catecholamines.
The American journal of cardiology.
1991 Nov; 68(11):1194-202. doi:
10.1016/0002-9149(91)90193-o. [PMID: 1683146] - H Pouleur, J Raigoso, M F Rousseau. Dopaminergic drugs in the management of chronic heart failure.
European heart journal.
1991 Aug; 12 Suppl C(?):29-34. doi:
10.1093/eurheartj/12.suppl_c.29. [PMID: 1680685] - A R Girbes, D J van Veldhuisen, A J Smit. Dopamine agonists, a new perspective in cardiovascular therapy?.
The Netherlands journal of medicine.
1991 Aug; 39(1-2):65-71. doi:
NULL. [PMID: 1683693] - A R Girbes, D J van Veldhuisen, A J Smit, A Drent-Bremer, S Meijer, W D Reitsma. Renal and neurohumoral effects of ibopamine and metoclopramide in normal man.
British journal of clinical pharmacology.
1991 Jun; 31(6):701-4. doi:
10.1111/j.1365-2125.1991.tb05597.x. [PMID: 1678273] - H Itoh. Clinical pharmacology of ibopamine.
The American journal of medicine.
1991 May; 90(5B):36S-42S. doi:
10.1016/0002-9343(91)90272-y. [PMID: 1675550] - J López-Sendón. Ibopamine in chronic congestive heart failure: hemodynamic and neurohumoral effects.
The American journal of medicine.
1991 May; 90(5B):43S-49S. doi:
10.1016/0002-9343(91)90273-z. [PMID: 1675551] - A J Man in't Veld. Ibopamine in the treatment of heart failure.
The American journal of medicine.
1991 May; 90(5B):50S-54S. doi:
10.1016/0002-9343(91)90274-2. [PMID: 1675552] - U Borchard. [Ibopamine--pharmacologic principles].
Zeitschrift fur Kardiologie.
1991; 80 Suppl 8(?):63-6. doi:
. [PMID: 1686693] - M Wehling, K Theisen. [Ibopamine--acute hemodynamic, renal and neurohumoral effects].
Zeitschrift fur Kardiologie.
1991; 80 Suppl 8(?):67-9. doi:
NULL. [PMID: 1686694] - D J Van Veldhuisen, A R Girbes, H J Crijns, A J Smit, W H Van Gilst, K I Lie. The oral dopamine agonist, ibopamine, in normal man: effects on rhythm, heart rate, blood pressure and catecholamines.
International journal of clinical pharmacology research.
1991; 11(3):159-65. doi:
NULL. [PMID: 1687321] - F X Kleber. [Ibopamine--clinical results].
Zeitschrift fur Kardiologie.
1991; 80 Suppl 8(?):71-6. doi:
NULL. [PMID: 1686695] - S H Taylor, V Cicchetti. Efficacy of ibopamine in the treatment of heart failure.
American heart journal.
1990 Dec; 120(6 Pt 2):1583-90. doi:
10.1016/0002-8703(90)90063-4. [PMID: 1978982] - R J Kasmer, R E Cutler, M A Munger, R C Jarvis, D Hricik, A R Nara, P Goldberg, J A Green. Single-dose effects of ibopamine hydrochloride on renal function in patients with congestive heart failure.
British journal of clinical pharmacology.
1990 Sep; 30(3):485-9. doi:
10.1111/j.1365-2125.1990.tb03802.x. [PMID: 2223427] - C H Ahn, G Shams, R L Schotzinger, D D Miller, D R Feller. Stereostructure activity relationships of catecholamines on human platelet function.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.).
1990 Jun; 194(2):149-56. doi:
10.3181/00379727-194-43071. [PMID: 2190233] - H Taniguchi, T Iwasaka, T Sugiura, Y Takayama, T Sumimoto, H Onoyama, H Takashima, S Nakamura, M Inada. Hemodynamic response to ibopamine in acute myocardial infarction.
Arzneimittel-Forschung.
1990 Apr; 40(4):428-31. doi:
NULL. [PMID: 2357243] - M Wehling, J Zimmermann, J Weil, R Gerzer, K Theisen. [Renal effects of ibopamine in comparison with furosemide in patients with mild heart failure].
Zeitschrift fur Kardiologie.
1990 Feb; 79(2):120-5. doi:
NULL. [PMID: 2157313] - C Casagrande, L Merlo, A La Regina. Development of dopaminergic drugs for the chronic treatment of congestive heart failure.
Journal of autonomic pharmacology.
1990; 10 Suppl 1(?):s85-93. doi:
10.1111/j.1474-8673.1990.tb00233.x. [PMID: 1983011] - F Salerno, P Incerti, S Badalamenti, E Lorenzano, G Graziani, A Morganti, P Ghirardi. Renal and humoral effects of ibopamine, a dopamine agonist, in patients with liver cirrhosis.
Archives of internal medicine.
1990 Jan; 150(1):65-9. doi:
NULL. [PMID: 1967522] - S Caponnetto, V Terrachini, C Canale, F Bruzzone, M A Masperone, L Pastorino, L Licciardello, G V Marchetti. Long-term treatment of congestive heart failure with oral ibopamine. Effects of rhythm disorders and neurohormonal alterations.
Cardiology.
1990; 77 Suppl 5(?):43-8. doi:
10.1159/000174695. [PMID: 1980633] - J López-Sendón. Hemodynamic and neurohumoral effects of ibopamine in patients with chronic congestive heart failure.
Cardiology.
1990; 77 Suppl 5(?):9-21. doi:
10.1159/000174690. [PMID: 1980634] - D J van Veldhuisen, A R Girbes, H J Crijns, A J Smit, P A de Graeff, K I Lie. Efficacy and safety of ibopamine in congestive heart failure.
Journal of autonomic pharmacology.
1990; 10 Suppl 1(?):s115-21. doi:
10.1111/j.1474-8673.1990.tb00237.x. [PMID: 1983005] - C Holubarsch, H Just. The safety profile of ibopamine, an alternative substance for treatment of chronic heart failure.
Cardiology.
1990; 77 Suppl 5(?):1-8. doi:
10.1159/000174689. [PMID: 2279251] - P Marchetti, F Sabino, R Giannarelli, A DiCarlo, V Cicchetti, R Navalesi. Safety of ibopamine in type II diabetic patients with mild chronic heart failure. A double-blind cross-over study.
Cardiology.
1990; 77 Suppl 5(?):57-62. doi:
10.1159/000174697. [PMID: 2279253] - M Wehling, J Zimmermann, K Theisen. Extracardial effects of oral ibopamine versus furosemide in patients with mild or moderate heart failure. A double-blind, randomized trial.
Cardiology.
1990; 77 Suppl 5(?):81-8. doi:
10.1159/000174701. [PMID: 2279257] - C Nappi, G Colace, P Affinito, M Taglialatela, G F Di Renzo, U Montemagno, L Annunziato. Ibopamine-induced reduction of serum prolactin level and milk secretion in puerperal women.
European journal of clinical pharmacology.
1990; 39(2):133-5. doi:
10.1007/bf00280046. [PMID: 2253662] - S Stefoni, G Mosconi, M Bonomini, R Prandini, A Nanni-Costa, M P Scolari, G Liviano-D'Arcangelo, G Cianciolo. The use of ibopamine in chronic renal failure: long-term results.
Contributions to nephrology.
1990; 81(?):264-9. doi:
10.1159/000418762. [PMID: 2093507] - C de Mey, D Enterling, I Meineke. Pharmacokinetic and pharmacodynamic interactions between single oral doses of ibopamine and food in normal man.
Arzneimittel-Forschung.
1989 Sep; 39(9):1138-43. doi:
NULL. [PMID: 2590265] - M G Ziegler, B Kennedy, H Elayan. Extraadrenal adrenaline formation by two separate enzymes.
Experientia.
1989 Aug; 45(8):718-20. doi:
10.1007/bf01974566. [PMID: 2759199] - L Dei Cas, M Metra, S Nodari, O Visioli. Efficacy of ibopamine treatment in patients with advanced heart failure: purpose of a new therapeutic scheme with multiple daily administrations.
Journal of cardiovascular pharmacology.
1989; 14 Suppl 8(?):S111-7. doi:
. [PMID: 2483436] - C Casagrande, L Merlo, R Ferrini, G Miragoli, C Semeraro. Cardiovascular and renal action of dopaminergic prodrugs.
Journal of cardiovascular pharmacology.
1989; 14 Suppl 8(?):S40-59. doi:
. [PMID: 2483441] - G Hasenfuss, H Just. Clinical relevance of long-term therapy with levodopa and orally active dopamine analogues in patients with chronic congestive heart failure.
Basic research in cardiology.
1989; 84 Suppl 1(?):191-6. doi:
10.1007/bf02650359. [PMID: 2573341] - C Missale, M Metra, S Sigala, M Memo, L Dei Cas, P F Spano. Inhibition of aldosterone secretion by dopamine, ibopamine, and dihydroergotoxine in patients with congestive heart failure.
Journal of cardiovascular pharmacology.
1989; 14 Suppl 8(?):S72-6. doi:
NULL. [PMID: 2483443] - E Riva, A Cavalli, G Abbondati, M C Cedrini, M Schleman, L M Fuccella. Ibopamine: long-term safety study in patients with congestive heart failure. The Italian Ibopamine Working Group.
International journal of clinical pharmacology research.
1989; 9(1):21-8. doi:
NULL. [PMID: 2707922] - C Sala, A Morganti, P Ferraris, G Ardeleani, P Venegoni, P Quorso, B Ambrosi, A Zanchetti. Dopaminergic control of aldosterone secretion is not mediated by atrial natriuretic factor in patients with essential hypertension.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension.
1988 Dec; 6(4):S336-8. doi:
10.1097/00004872-198812040-00104. [PMID: 2977175]
